Oral contraceptive estrogen dose considerations

This publication has 36 references indexed in Scilit:

• Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
  Published by Elsevier ,1996
• Smoking and cycle control among oral contraceptive users
  American Journal of Obstetrics and Gynecology, 1996
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Smokers Have Less Dense Bones and Fewer Teeth
  Journal of the Royal Society of Health, 1994
• High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect
  European Journal Of Cancer, 1992
• Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group
  Archives of internal medicine (1960), 1991
• The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
  New England Journal of Medicine, 1987
• Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
  Published by American Medical Association (AMA) ,1987
• The Effect of Estrogen Dose on Postmenopausal Bone Loss
  New England Journal of Medicine, 1983